Research on stress ulcer prophylaxis: Wrong questions, wrong answers?

Critical Care Medicine

Volumn 27, Issue 1, 1999, Pages 16-17

  Tryba, Michael ^a  

^a KLINIKUM KASSEL   (Germany)

Author keywords

Costs; Dose; H2 antagonists; Prophylaxis; Stress ulcer; Sucralfate; Survey

Indexed keywords

ANTACID AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; SUCRALFATE;

COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG EFFICACY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; PNEUMONIA; PRIORITY JOURNAL; STOMACH PH; STRESS ULCER;

ANTI-ULCER AGENTS; COST-BENEFIT ANALYSIS; CRITICAL CARE; HUMANS; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RESEARCH DESIGN; UNITED STATES;

EID: 0032893571     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199901000-00011     Document Type: Editorial

References (20)

1. 1. Priebe HJ, Skillman JJ, Bushnell LS, et al: Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients. N Engl J Med 1980; 302: 426-430
2. 2. Zinner MJ, Zuidema GD, Smith PL, et al: The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 1981; 153:214-220
3. 3. Driks MR, Craven DE, Celli BR, et al: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987; 317: 1376-1382
4. 4. Tryba M: Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: Sucralfate versus antacids. Am J Med 1987; 83(3B):117-124
5. 5. Apte NM, Karnad DR, Medhekar TP, et al: Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial. Crit Care Med 1992; 20:590-593
6. 6. Eddleston JM, Vohra A, Scott P, et al: A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate-or ranitidine-treated intensive care unit patients. Crit Care Med 1991; 19:1491-1496
7. 7. Laggner AN, Lenz K, Graninger W, et al: [Prevention of stress hemorrhage in an internal medicine intensive care station: Sucralfate versus ranitidine]. Anaesthesist 1988; 37:704-710
8. 8. Prod'hom G, Leuenberger P, Koerfer J, et al: Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994; 120:653-662
9. 9. Simms HH, DeMaria E, McDonald L, et al: Role of gastric colonization in the development of pneumonia in critically ill trauma patients: Results of a prospective randomized trial. J Trauma 1991; 31:531-536
10. 10. Fabian TC, Boucher BA, Croce MA, et al: Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993; 128:185-191
11. 11. Pickworth KK, Falcone RE, Hoogeboom JE, et al: Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: A comparison of sucralfate and ranitidine. Crit Care Med 1993; 21:1856-1862
12. 12. Cook D, Reeve B, Guyatt G, et al: Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275:308-314
13. 13. Cook D, Guyatt G, Marshall J, et al: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338:791-797
14. 14. O'Keefe GE, Gentilello LM, Maier RV: Incidence of infectious complications associated with the use of histamine-2-receptor antagonists in critically ill trauma patients. Ann Surg 1998; 227:120-125
15. 15. Lam NP, Lê PDT, Crawford SY, et al: National survey of stress ulcer prophylaxis. Crit Care Med 1999; 27:98-103
16. 16. Gastinne H, Wolff M, Delatour F, et al: A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992; 326:594-599
17. 17. Ben-Menachem T, McCarthy BD, Fogel R, et al: Prophylaxis for stress-related gastrointestinal hemorrhage: A cost-effectiveness analysis. Crit Care Med 1996; 24:338-345
18. 18. Schumock GT, Lam NP, Winkler SR, et al: Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients. Pharmacoeconomics 1996; 9:455-466
19. 19. Pitimana-aree S, Forrest D, Brown G, et al: Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med 1998; 24:217-223
20. 20. Tryba M, Cook D: Current guidelines on stress ulcer prophylaxis. Drugs 1997; 54:581-596